From: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
Characteristic
Number
Age
63 (range 34-75)
ECOG PS 0*
3
ECOG PS 1
16
Males
12
Females
7
White
18
Hispanic
1
Prior surgery
6
Prior radiation
2
Prior chemotherapy regimens
5
8
≥ 3